There’s more to come from Froome and Thomas despite INEOS omission

By Raoul Metcalfe

It’s hard to know just what to expect from the 107th edition of the Tour de France. Not only does this year’s route deviate from the traditional course by introducing a mountain stage on the second day, but by conducting the race mid-pandemic the organisers may have unwittingly made the race more exciting than ever right from the Grand Départ in Nice.

With a mobile testing lab and a policy stipulating that teams with two positive tests face exclusion, there is the very real possibility that any contender for the race leader’s yellow jersey could be booted out, while the Tour itself may not even finish given the current surge of cases in France.

Covid speculation aside, the main talking point in the build up to this year’s race is the absence of former winners Chris Froome and Geraint Thomas from the Team INEOS roster. Their omission means that for the first time in a decade the race starts without a British rider among the favourites.

But why leave out two former champions? After all, together they have carved the recent history of the race, winning five of the last seven between them.

Many believe that this spells the end for British dominance in La Grande Boucle, but such a declaration seems premature. The problem is in fact far more acute, and is no more complicated than the matter of the riders’ recent form. In short, both Froome and Thomas have found themselves way below the level required to challenge for a three-week Grand Tour. For a team obsessed with the idea of marginal gains, this move seems self-evident.

The pair were both repeatedly dropped by their own teammates from the group of general classification contenders early on in the mountain stages of the Critérium du Dauphiné, an event where Froome and Thomas cracked catastrophically.

They were struggling to ride up against the likes of Guillaume Martin, a rider who boasts only one top ten finish in the Tour among his palmarès, and finished half an hour behind stage winner Seb Kuss on the final day.

Four-time champion Froome is, by his own admission, still below his best, having had this season disrupted not only by Covid-19 but also from an awful crash last year. As he put it, “I think it’s a lot more realistic to target the Vuelta as it gives me a chance to get stuck into something that is deliverable.

“People have to remember that I have come back from a horrendous crash last year where I fractured a lot of bones in my body. The recovery is complete. I don’t have any pain. I don’t have any lingering issues. But certainly, that was a big knock to me and I’m still coming back to that full level of fitness.”

Therefore, the narrative of Froome’s absence must be seen as part of a sensible and remarkable comeback, all culminating with the prospect of victory at the Vuelta.

Thomas’ situation is more perplexing. He is a rider who has in the past found his peak form during the season by racing. Having been denied the chance to do so by Covid, he was always going to struggle in a condensed season where he couldn’t get up to speed. He may have hoped to use the Tour to ride himself into contention for the Giro D’Italia, but it appears that INEOS were unwilling to spare a space for such preparation.  

Neither riders’ hopes of starting were helped by the fact that INEOS currently boast an exceptionally strong squad. They did not have to look far down their roster to find riders in much better shape than Froome and Thomas – namely last year’s winner Egan Bernal.

Froome’s absence must be seen as part of a remarkable comeback, culminating with victory at Vuelta.

Where in the past INEOS have operated with a de facto of supporting their best placed rider going into the final week of the Tour, they can now direct all of their resources from the start to Bernal, and avoid the awkward situation of having to support two previous winners out of loyalty and diverting support away from their strongest rider.  

The emphasis of the INEOS announcement was not directed towards their exclusions. Instead, it was part of a formidable declaration of intent: that the team would target all three of cycling’s Grand Tours. As their Twitter put it: “Three leaders. One team. One purpose.”

Perhaps then it would be better to think of this decision not as an exclusion, but as a pragmatic response to the current situation – offering both riders the chance to salvage something from this most disrupted of seasons.

As Brailsford put it, “Geraint will target the Giro and take on the opportunity to double up his Tour de France win with another Grand Tour title, with the aim of being the first Welshman to win it. 

“In turn, Chris Froome will target the Vuelta. Chris is a legend of our sport, a true champion who has demonstrated incredible grit and determination to come back from his crash last year. We want to support him to compete for another Grand Tour title and the Vuelta gives him that little bit more time to continue his progress to the top level.”

It is now safe to say that the certain murmurings within British cycling media, that claimed Brailsford’s announcement formed some part of an elaborate strategy to deceive other teams through a game of 4D chess, are now patently ridiculous. It may only have been announced that Froome and Thomas would be sitting this one out with ten days to go, but for anyone following the Dauphiné, the writing was on the wall.

However, it would be too early to write the obituary for this era of dominance from British Cycling. Viewer retention may well fall in the UK – a likelihood not helped by Mark Cavendish’s failure to make the grade for Team Bahrain – but it is far from game over for Froome, who could very well finish his recovery with a Grand Tour win before leaving to join the Israel Start-Up Nation. The same goes for Geraint Thomas, who could by all means still win the Giro.

And then of course there is next season, which promises an exciting new era for British Cycling as former Vuelta winner Adam Yates will have joined INEOS. There is plenty more to come. We will just have to wait and see.

Image: babbo1957 via Creative Commons